SCHEMBL6868423

SCHEMBL6868423

C=C(O)/C=C\C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21049241 1.00
SCHEMBL3463324 1.00
SCHEMBL23845797 0.78
SCHEMBL10306724 0.76
SCHEMBL2617106 0.76
SCHEMBL19337432 0.76
SCHEMBL20391253 0.74 ALDH1A1 (0.36)
SCHEMBL14219877 0.74
SCHEMBL8223479 0.74
SCHEMBL12687401 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170260315-A1 NOVOLAC TYPE PHENOL RESIN, MANUFACTURING METHOD THEREFOR, PHOTOSENSITIVE COMPOSITION, RESIST MATERIAL AND COATING FILM DIC CORPORATION (JP) 2017-09-14 US disclosed
WO-2013084249-A1 DIETARY SUPPLEMENT COMPRISING VERBASCOSIDE AND TEUPOLIOSIDE FOR LOWERING LDL AND INCREASING HDL LOMBARDATRADING SRL (IT) 2013-06-13 WO disclosed
WO-2013003383-A1 BRIDGED BICYCLIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS KYORIN PHARMACEUTICAL CO., LTD. (JP) 2013-01-03 WO disclosed
WO-2011033009-A1 N- [2-HYDROXYCARBAMOYL-2- (PIPERAZINYL) ETHYL] BENZAMIDE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS TACE INHIBITORS GALDERMA RESEARCH & DEVELOPMENT (FR) 2011-03-24 WO disclosed
WO-2010077101-A4 NOVEL THIAZOLIDINEDIONE DERIVATIVE AND USE THEREOF 조선대학교산학협력단 (KR) 2011-01-13 WO disclosed
US-20100048577-A1 Method for treating benign prostate hyperplasia using resveratrol NEW YORK INSTITUTE OF TECHNOLOGY 2010-02-25 US disclosed
US-20100048577-A1 Method for treating benign prostate hyperplasia using resveratrol NEW YORK INSTITUTE OF TECHNOLOGY 2010-02-25 US disclosed
WO-2009142842-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2009-11-26 WO disclosed
WO-2009109570-A1 INHIBITORS FOR BRASSINOSTEROID SIGNALLING GMI - GREGOR-MENDEL-INSTITUT FÜR MOLEKULARE PFLANZENBIOLOGIE GMBH (AT) 2009-09-11 WO disclosed
EP-2098510-A1 Inhibitors for brassinosteroid signalling GMI - Gregor-Mendel-Institut für Molekulare Pflanzenbiologie GmbH (AT) 2009-09-09 EP disclosed